This electronic patch helps men last four times longer in bed
Premature ejaculation is a major issue for a lot of men, as the most common male sexual dysfunction, affecting an estimated 20 to 30 percent of men. This can clearly affect your sex life, creating conflict within your relationship and lower your self-esteem. So if there was a way to completely bypass this issue entirely, that would make a lot of lives considerably easier, right?
An Israeli medical devices startup named Virility Medical has supposedly found the answer, and their successful prototype could change the lives of men all over the world. The company has recently announced the completion of a hospital-based trial for its problem-saving device: a single-use disposable patch. All you have to do is place it on the skin of the perineum before sex, then get rid of it after one use.
Strangely enough, you can control the patch via a smartphone app. Once you've set your own parometers of when the device will come into play, the patch can send a low-frequency electrical current that contracts the muscle responsible for ejaculation, thereby delaying climax.
The trial involved 20 men, and was conducted at the Clinic for Sexual Dysfunction at Rambam Health Care Campus in Haifa. Participants reported an average of a 3.5-fold increase in delaying ejaculations, with no side-effects. This is a big deal since previous treatments have had limited effectiveness and often come with side-effects such as headache, nausea, diminished libido and erectile dysfunction.
"This particular muscle is close to the surface of the skin so it can be stimulated electrically," said biomedical engineer Tal Gollan, founder and CEO of Virility Medical. He began this pursuit 18 months ago, bringing together a team of medical experts and advisers.
"An estimated 79 million men suffer from premature ejaculation in the United States and in the EU," he said. "We're bringing a groundbreaking, effective and simple solution, with no side effects compared to existing products on the market."
"According to a market survey we conducted, this has a market potential significantly larger than the Viagra pill," said Zohar Gendler, CEO of NGT3, which took Virility Medical into its portfolio. "The innovative and very effective technology of Virility Medical will be a game changer"
Virility Medical has raised around $858,000 already for the project, and will embark on a second funding round in the coming months. A second trial will take place soon, using an advanced prototype, which will involve between 30 and 45 patients this time around.
Once the results of that test and the lengthy procedure of obtaining regulatory approvals is completed, Gollan expects will be available to the public, likely there to be purchased in the next two years. If this catches on and provides what it promises to, by time we hit 2020 this issue could be a thing of the past.